E‐cadherin and urokinase‐type plasminogen activator tissue status in gastric carcinoma

Cancer

Volumn 76, Issue 6, 1995, Pages 941-953

  Yonemura, Yutaka ^a   Nojima, Naomi ^a   Kaji, Masahide ^a   Fujimura, Takashi ^a   Itoh, Hiroshi ^a   Ninomiya, Itasu ^a   Miyazaki, Itsuo ^a   Endo, Yoshio ^a   Sasaki, Takuma ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

E cadherin; gastric cancer; prognosticator in gastric cancer; proliferating cell nuclear antigen; urokinase type plasminogen activator

Indexed keywords

UROKINASE; UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER STAGING; DIAGNOSTIC VALUE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; STOMACH BIOPSY; STOMACH CARCINOMA;

ADULT; AGED; ANEUPLOIDY; CADHERINS; CARCINOMA; HUMAN; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MIDDLE AGE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PLOIDIES; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; URINARY PLASMINOGEN ACTIVATOR;

EID: 0029090083     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19950915)76:6<941::AID-CNCR2820760606>3.0.CO;2-I     Document Type: Article

References (37)

1. Tumor invasion and the extracellular matrix
2. Cadherin cell adhesion receptors as a morphogenetic regulator
3. E‐cadherin expression in squamous cell carcinoma of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis
4. E‐cadherin: a differentiation marker in thyroid malignancies
5. Expression of the cellular adhesion molecule E‐cadherin is reduced or absent in high‐grade prostate cancer
6. Molecular aspects of tumor cell invasion and metastasis
7. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane
8. Tumor invasion and metastasis: role of the extracellular matrix
9. Hyperthermo‐chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination
10. Neoadjuvant chemotherapy for high‐grade advanced gastric cancer
11. AMex method
12. Flow cytometry in tumor cell receptor analysis: surgery of the literature and recent developementc concerning the urokinase‐type plasminogen activator (uPA)
13. Expression of E‐and P‐cadherin in gastric carcinomas
14. Plasminogen activators, plasminogen activator inhibitors and procoagulant analysis in twenty human tumor cell lines
15. Transforming growth factor‐switches the pattern of integrins expressed in MG‐63 human osteosarcoma cells and causes a selective loss of cell adhesion to laminin
16. Correlation of DNA ploidy and clinical outcome in Borrmann type 4 gastric cancer
17. Loss of basement membrane components by invasive tumors but not by their benign counterparts
18. Unstable expression of E‐cadherin adhesion molecules in metastatic ovarian tumor cells
19. Adhesion molecules during somstogenesis in the avian embryo
20. Novel function for integrins in keratinocyte cell‐cell interactions
21. Cadherins: a molecular family important in selective cell‐cell adhesion
22. Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin‐mediated cell‐cell adhesion
23. Immunohistochemical evaluation of E‐cadherin adhesion molecule expression in human gastric cancer
24. Expression of E‐cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis
25. Exclusion of dextrans by meshworks of collagenous fibers
26. Antibodies to plasminogen inhibitor inhibit human tumor metastasis
27. Expression of human recombinant plasminogen activators enhance invasion and experimental metastasis of Ha‐ras transformed NIH 3T3 cells
28. Urokinase‐plasminogen activator, a marker for aggressive breast carcinomas
29. The urokinase type of plasminogen activator in cancer of digestive tracts
30. Relationship between plasminogen activators and stomach carcinoma stage
31. Stimulation of urokinase‐type plasminogen activator expression by blockage of E‐cadherin‐dependent cell‐cell adhesion
32. Retrospective analysis of the prognostic significance of DNA ploidy patterns and S‐phase fraction in gastric carcinoma
33. Differentiation of growth patterns of early gastric carcinoma determined by cytophotometric DBA analysis
34. Plasminogen activators in human gastric cancers: correlation with DNA ploidy and immunohistochemical staining
35. Heterogeneity of DNA ploidy in gastric cancer
36. Correlation of DNA ploidy and proliferative activity in human gastric cancer